Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

431 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 431 results

Not applicableStudy completedNCT04682548
What this trial is testing

Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients

Who this might be right for
Multiple SclerosisCovid19
NYU Langone Health 920
Not applicableUnknownNCT05217784
What this trial is testing

COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF)

Who this might be right for
Cystic FibrosisCovid19
Rabin Medical Center 70
Early research (Phase 1)Study completedNCT05293678
What this trial is testing

Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody/Ies in Adult Healthy Volunteers as Related to COVID-19

Who this might be right for
Healthy
Regeneron Pharmaceuticals 104
Early research (Phase 1)Study completedNCT04567810
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)

Who this might be right for
Covid19
Stanford University 48
Not applicableUnknownNCT04543006
What this trial is testing

Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19

Who this might be right for
Covid19
University Hospital, Grenoble 170
Testing effectiveness (Phase 2)UnknownNCT04840459
What this trial is testing

Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

Who this might be right for
Covid19
Sohail Rao 1,000
Not applicableUnknownNCT04627623
What this trial is testing

Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration

Who this might be right for
Covid19Respiratory Tract InfectionsSevere Acute Respiratory Syndrome+4 more
Medical University of Silesia 6,000
Large-scale testing (Phase 3)UnknownNCT04395170
What this trial is testing

Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Lifefactors Zona Franca, SAS 75
Not applicableStudy completedNCT04750720
What this trial is testing

Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection

Who this might be right for
Covid19SARS-CoV-2
Centre Hospitalier Régional d'Orléans 187
Not applicableUnknownNCT04961502
What this trial is testing

Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions

Who this might be right for
Elderly People Institutionalized in Long-term Care Services
Gérond'if 80
Not applicableStudy completedNCT04619407
What this trial is testing

Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers

Who this might be right for
SARS-CoV-2
University Medicine Greifswald 142
Not applicableStudy completedNCT04726137
What this trial is testing

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19

Who this might be right for
Sars-Cov2 Antibodies in Children and Adolescents Living With HIV
PENTA Foundation 906
Not applicableUnknownNCT05079165
What this trial is testing

Covid Vaccination in Liver Transplantation

Who this might be right for
COVID-19
University Hospital, Strasbourg, France 300
Not applicableUnknownNCT04425759
What this trial is testing

Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19)

Who this might be right for
Covid19Corona Virus InfectionSARS-CoV 2+1 more
Hospital de Mataró 2,400
Not applicableStudy completedNCT05074680
What this trial is testing

COVID-19 Antibody Responses In Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Insel Gruppe AG, University Hospital Bern 5
Early research (Phase 1)Study completedNCT05181683
What this trial is testing

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 45
Post-approval studies (Phase 4)UnknownNCT04796402
What this trial is testing

Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19

Who this might be right for
Covid19
Fraser Health 576
Not applicableUnknownNCT05508295
What this trial is testing

Long COVID-19 and MAB Study

Who this might be right for
COVID-19
MultiCare Health System Research Institute 300
Large-scale testing (Phase 3)Study completedNCT04452318
What this trial is testing

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay

Who this might be right for
Healthy Participants
Regeneron Pharmaceuticals 3,303
Not applicableUnknownNCT05175989
What this trial is testing

SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

Who this might be right for
COVID-19 Vaccine
Rabin Medical Center 150
Next Page